These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Use of a new rifamycin SV derivative in chronic urinary infections. Posada HR; Sanchez AS Arzneimittelforschung; 1970 Jan; 20(1):101-3. PubMed ID: 4909437 [No Abstract] [Full Text] [Related]
5. [Urinary tract infections. Experimental production in rats]. Rosini S; Benetti D G Batteriol Virol Immunol Microbiol; 1972 Jan; 65(1):50-8. PubMed ID: 4598648 [No Abstract] [Full Text] [Related]
6. Spheroplast infections of the urinary tract. Gnarpe H Scand J Infect Dis; 1970; 2(1):59-64. PubMed ID: 4999737 [No Abstract] [Full Text] [Related]
7. Carbenicillin therapy of urinary tract infections due to difficult uropathogens. I. indole-positive Proteus. Fieldelman W Curr Ther Res Clin Exp; 1975 Jul; 18(1 s suppl):231-40. PubMed ID: 808383 [No Abstract] [Full Text] [Related]
8. Experimental ascending spheroplast infections of the urinary tract. Some factors affecting the viability of spheroplasts within the urinary tract. Gnarpe H Acta Pathol Microbiol Scand B Microbiol Immunol; 1970; 78(2):196-202. PubMed ID: 5275076 [No Abstract] [Full Text] [Related]
9. [About the Influence of high doses of penicillin on a proteus vulgaris Infection of the urinary tract]. WOLF J Dtsch Med Wochenschr; 1948 Oct; 73(39-40):492. PubMed ID: 18207759 [No Abstract] [Full Text] [Related]
11. The inflammatory reaction and urinary leucocytes in ascending urinary-tract infections. An experimental study on rabbits infected with Proteus vulgaris X 19 and Escherichia coli 06. Gnarpe H; Olding L Acta Pathol Microbiol Scand B Microbiol Immunol; 1970; 78(2):208-14. PubMed ID: 4922733 [No Abstract] [Full Text] [Related]
14. [Bacteriuria, urinary infection and pyelonephritis: critical analysis of the results obtained during the years 1958-1978. Part II]. Vivaldi E; González E; Conejeros M; Bergeret I; Zemelman R Rev Med Chil; 1979 Oct; 107(10):945-9. PubMed ID: 399056 [No Abstract] [Full Text] [Related]
15. Preventive and therapeutic administration of an indigenous Lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model. Fraga M; Scavone P; Zunino P Antonie Van Leeuwenhoek; 2005 Jul; 88(1):25-34. PubMed ID: 15928974 [TBL] [Abstract][Full Text] [Related]
16. [Urinary tract infections due to Proteus rettgeri]. Bauernfeind A Fortschr Med; 1973 May; 91(13):588. PubMed ID: 4701128 [No Abstract] [Full Text] [Related]
17. Isolation of L-forms in recurrent urinary tract infections. Crowe CC; Koblasz KK Am J Med Technol; 1971 Sep; 37(9):367-70. PubMed ID: 4938417 [No Abstract] [Full Text] [Related]
18. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection]. Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080 [TBL] [Abstract][Full Text] [Related]
19. Rare occurrence of Proteus vulgaris in faeces: a reason for its rare association with urinary tract infections. Senior BW; Leslie DL J Med Microbiol; 1986 Mar; 21(2):139-44. PubMed ID: 3512839 [TBL] [Abstract][Full Text] [Related]
20. [Acetylhydroxamic acid in the treatment of nephrolithiasis, caused by infection with urease forming microorganisms]. Lorenz J; Lorenz K; Dabrowska B; Kowal R Z Urol Nephrol; 1989 Dec; 82(12):685-9. PubMed ID: 2698024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]